Ingevity (NGVT) Earning Somewhat Negative Media Coverage, Analysis Finds

Media coverage about Ingevity (NYSE:NGVT) has trended somewhat negative recently, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ingevity earned a daily sentiment score of 0.00 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.9469314236175 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

These are some of the news stories that may have effected Accern Sentiment’s scoring:

Ingevity (NGVT) opened at $73.16 on Thursday. The company has a quick ratio of 1.34, a current ratio of 2.36 and a debt-to-equity ratio of 1.92. The stock has a market cap of $3,040.00 and a PE ratio of 32.66. Ingevity has a twelve month low of $51.01 and a twelve month high of $80.18.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Wednesday, November 1st. The company reported $0.86 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.75 by $0.11. The business had revenue of $264.10 million during the quarter, compared to the consensus estimate of $260.88 million. Ingevity had a net margin of 9.86% and a return on equity of 58.14%. The business’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.64 EPS. analysts forecast that Ingevity will post 2.49 earnings per share for the current fiscal year.

A number of equities analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Ingevity from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. Loop Capital cut their price target on shares of Ingevity from $83.00 to $80.00 and set a “buy” rating for the company in a report on Tuesday, December 26th. Rowe reiterated an “outperform” rating and issued a $90.00 price target (up previously from $80.00) on shares of Ingevity in a report on Thursday, November 30th. BidaskClub upgraded shares of Ingevity from a “hold” rating to a “buy” rating in a report on Saturday, November 4th. Finally, Jefferies Group increased their price target on shares of Ingevity from $71.00 to $84.00 and gave the company a “buy” rating in a report on Friday, November 3rd. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $78.17.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Markets Daily and is owned by of Markets Daily. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at

Ingevity Company Profile

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.

Insider Buying and Selling by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply